🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Reckitt weighs shelving infant nutrition unit sale - Bloomberg News

Published 28/06/2022, 15:11
© Reuters. FILE PHOTO: Mead Johnson's product Enfamil baby formula are displayed on a store shelf in New York City, U.S., February 10, 2017. REUTERS/Brendan McDermid
FORTY
-
N1WS34
-

(Reuters) -Britain's Reckitt Benckiser Group is considering if it should shelve the sale of its infant nutrition unit, as high-profile deals fall victim to a worsening financing market , Bloomberg News reported on Tuesday.

Talks between the Enfamil baby formula maker and potential buyers have stalled in recent weeks, the report said https://bloom.bg/3bBJwwk, citing people familiar with the matter.

Reckitt declined to comment on the report.

Bloomberg News reported that disagreements over valuation, a lack of available funding and an ongoing baby formula crisis in the U.S. complicated efforts to sell the business.

The U.S. baby formula crisis had boosted profits at Reckitt and helped it grab the top spot in a $5.8 billion-a-year market.

© Reuters. FILE PHOTO: Mead Johnson's product Enfamil baby formula are displayed on a store shelf in New York City, U.S., February 10, 2017. REUTERS/Brendan McDermid

Reckitt has not made a final decision on whether to formally pull the sale, the report said.

Shares of the consumer goods company were trading 0.1% higher by 1419 GMT.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.